Clinical trials represent the most important part of a drug development cycle. However, as high as 85% of all clinical trials will be completed with delays, creating unnecessary costs. At HYGEIA Research, we know that it is indeed possible not only to decrease delays but to avoid them and that even most complexed clinical trials can be completed on time.